share_log

Vaxcyte Q1 EPS $(0.85) Beats $(1.09) Estimate

Benzinga ·  May 8 17:26

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.09) by 22.02 percent. This is a 21.43 percent decrease over losses of $(0.70) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment